Wolfe Drug Testing Concord, NC - 28027

Wolfe Drug Testing is categorized under Human Resource Consultants in Concord, NC and active since 1985.

Wolfe Drug Testing was established in 1985, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Human Resource Consultants business, which does work in the B2B market, and is classified as a Human Resource Consultants, under code number 6215110 by the NAICS.

If you are seeking more information, feel free to contact Jim Wolfe, President at the company’s single location by writing to 681 Cabarrus Avenue West, Concord, North Carolina NC 28027 or by phoning (704) 788-6441. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Wolfe Drug Testing
Contact Person: Jim Wolfe, President
Address: 681 Cabarrus Avenue West, Concord, North Carolina 28027
Phone Number: (704) 788-6441
Website Address: wolfeinc.com
Annual Revenue (USD): $2.500.000 to $4.999.999
Founded: 1985
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Human Resource Consultants
SIC Code: 8742
NAICS Code: 6215110
Share This Business:

Wolfe Drug Testing was started in 1985 to provide professional Human Resource Consultants under the SIC code 8742 and NAICS code 6215110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.

Feel free to contact Jim Wolfe, President for inquiries that concern Wolfe Drug Testing by calling the company number (704) 788-6441, as your correspondence is most welcome. Additionally, the physical location of the single location of Wolfe Drug Testing can be found at the coordinates 35.39683,-80.60416 as well as the street address 681 Cabarrus Avenue West in Concord, North Carolina 28027.

For its online presence, you may visit Wolfe Drug Testing’s website at wolfeinc.com and engage with its social media outlets through on Twitter and on Facebook.